TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
28.53
-0.91 (-3.11%)
At close: Aug 25, 2025, 4:00 PM
28.62
+0.09 (0.32%)
After-hours: Aug 25, 2025, 4:18 PM EDT

TG Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover TG Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $42.5, which forecasts a 48.97% increase in the stock price over the next year. The lowest target is $22 and the highest is $55.

Price Target: $42.5 (+48.97%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$22$42.5$50$55
Change-22.89%+48.97%+75.25%+92.78%
* Price targets were last updated on Mar 4, 2025.

Analyst Ratings

The average analyst rating for TG Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy444442
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total666664

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$55
Strong BuyReiterates$55+92.78%Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$55
Strong BuyReiterates$55+92.78%Jan 15, 2025
JP Morgan
JP Morgan
Buy
Maintains
$30$43
BuyMaintains$30$43+50.72%Nov 25, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$49$55
Strong BuyMaintains$49$55+92.78%Nov 5, 2024
Goldman Sachs
Goldman Sachs
Hold
Maintains
$20$22
HoldMaintains$20$22-22.89%Nov 5, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
600.69M
from 329.00M
Increased by 82.58%
Revenue Next Year
870.93M
from 600.69M
Increased by 44.99%
EPS This Year
0.80
from 0.15
Increased by 432.66%
EPS Next Year
1.87
from 0.80
Increased by 134.47%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
152.00K6.69M2.79M233.66M329.00M600.69M870.93M1.11B
Revenue Growth
-4,300.66%-58.36%8,290.02%40.80%82.58%44.99%27.34%
EPS
-2.42-2.63-1.650.090.150.801.872.45
EPS Growth
----68.04%432.66%134.47%30.81%
Forward PE
-----35.7115.2311.64
No. Analysts
-----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High622.7M973.4M1.3B
Avg600.7M870.9M1.1B
Low571.1M739.4M942.5M

Revenue Growth

Revenue Growth20252026202720282029
High
89.3%
62.0%
52.4%
Avg
82.6%
45.0%
27.3%
Low
73.6%
23.1%
8.2%

EPS Forecast

EPS20252026202720282029
High1.012.613.31
Avg0.801.872.45
Low0.521.311.92

EPS Growth

EPS Growth20252026202720282029
High
572.0%
227.2%
76.6%
Avg
432.7%
134.5%
30.8%
Low
246.3%
64.4%
2.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.